| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8652764 | The Annals of Thoracic Surgery | 2018 | 8 Pages |
Abstract
Despite being at high risk for extrapulmonary complications, patients undergoing bilateral lung transplantation for scleroderma have similar 1-year and 5-year survival as those with restrictive lung disease. Transplantation is a reasonable treatment option for a carefully selected population of candidates.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Edward Y. MD, Ahmad MD, Neeraj MD, Duc T. MD, PhD, J. Georges MD, Erik E. MD, Thomas MD, Edward A. PhD, MPH, Brian A. MD, PhD, Thomas E. MD, Scott A. MD,